AI cancer cures slowed by chip shortage, says Arm boss
dabinat · hn · 2026-09-08
Arm's CEO told the BBC that chip shortages are slowing AI-driven cancer research, arguing that compute constraints have become a real bottleneck for biomedical AI and calling for expanded chip production.
More from Infra
- Nearly half of Claude revenue now flows through cloud marketplace commitments, up from 11% — BenBajarin · 2026-10-26
- Anthropic ARR goes vertical after price cuts: tokens up 4x, $100B+ ARR back in play — GavinSBaker · 2026-10-26
- Alex Banks argues power caps GPU supply, real risk is demand cooling first — thealexbanks · 2026-10-26
- Analyst: Ant has the most fungible AI workload of any model provider today — BenBajarin · 2026-10-26
- Anthropic S-1: training infra edge cut per-task cost 40% and doubled revenue growth — BenBajarin · 2026-10-26
- Rewriting scaling law study: optimal synthetic data share rises from 10% to 32% with compute — heghbalz · 2026-10-26